Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

Creator
0 followers

Insilico Medicine founder; posts AI drug discovery and aging research developments.

Liquid AI Launches Foundation Model for Drug Discovery
SocialApr 15, 2026

Liquid AI Launches Foundation Model for Drug Discovery

@semafor World Economy brought together most of the global CEOs to Washington, DC. And it is a pleasure and honor to meet our amazing partner @ramin_m_h of Liquid AI . We just published the Liquid Foundation Model capable...

By Alex Zhavoronkov, PhD
Aging
SocialApr 11, 2026

Aging

RIP Dr Skulachev who made serious contributions to the ROS theory of aging. Unfortunately, no FDA-approved drug out of his work yet. One of my goals is to have several FDA approved drugs before or after I die. Papers and...

By Alex Zhavoronkov, PhD
Frontier AI's Rapid Threat Looms if Misused
SocialApr 11, 2026

Frontier AI's Rapid Threat Looms if Misused

We live in such a perfect world considering where frontier AI could easily take us in under a year if the villains were a bit more creative. Some of the very realistic ideas that are on the surface I am...

By Alex Zhavoronkov, PhD
Intel Remains the Sole US Alternative to TSMC
SocialApr 10, 2026

Intel Remains the Sole US Alternative to TSMC

@LipBuTan1 brought Intel back to former glory. In reality, it is the only alternative to TSMC on the ground in the US https://t.co/XIwPsNxGo3

By Alex Zhavoronkov, PhD
Aim for Peak Longevity, Not Just Healthspan
SocialApr 9, 2026

Aim for Peak Longevity, Not Just Healthspan

Check out my new https://t.co/lzzxyoQMxZ post titled "Peakspan: The True North of Longevity and Why We Must Aim Beyond Healthspan?". Link in the comments. Geroscience got a bit too woke for my taste. Can we set staying at or...

By Alex Zhavoronkov, PhD
Anthropic Proves Woke Can Drive Rapid Innovation
SocialApr 9, 2026

Anthropic Proves Woke Can Drive Rapid Innovation

Anthropic just proved that being woke does not mean being unproductive. I am amazed by the speed they manage to ship, partner and even announce. Mythos will be a total game changer. Unfortunately, it will suck in drug discovery tasks...

By Alex Zhavoronkov, PhD
Real Progress Lies in 0‑to‑PCC Data, Not AI Hype
SocialApr 7, 2026

Real Progress Lies in 0‑to‑PCC Data, Not AI Hype

Check out my article in @FastCompany on AI drug discovery revolution. From one perspective, it may feel like I am turning into a version of Derek Lowe - AI skeptic. And when I read another interview with the IT...

By Alex Zhavoronkov, PhD
Prioritize Peakspan Over Healthspan in Drug Discovery
SocialApr 7, 2026

Prioritize Peakspan Over Healthspan in Drug Discovery

I think that it is easier to measure Peakspan than Healthspan. And something we should study hard. I don't want just healthspan - I want to be at my peak. Not for myself but for all of you - we...

By Alex Zhavoronkov, PhD
Bootstrapped Cryo‑AI: LLMs Power Life‑Saving Freeze Tech
SocialApr 7, 2026

Bootstrapped Cryo‑AI: LLMs Power Life‑Saving Freeze Tech

Meet Dr. Mark Woodward, undergrad and grad from Stanford, PhD from Harvard, Many years at Google as part of Google brain. One day he realizes that we need the enabling technology to pause biological time for patients that are about...

By Alex Zhavoronkov, PhD
Peakspan: Key Concept Shaping Economy and Everyday Life
SocialApr 6, 2026

Peakspan: Key Concept Shaping Economy and Everyday Life

You will see many posts from me on the concept of Peakspan and Peakspan Extension. Here is what Peakspan is and why it is important. It is important for our economy and for our life. #Peakspan https://t.co/yGL6zMr4Rh

By Alex Zhavoronkov, PhD
Google Must Unify Services Into a Closed AI Ecosystem
SocialApr 6, 2026

Google Must Unify Services Into a Closed AI Ecosystem

All Google needs to do now is to connect all its services in a closed OpenClaw-like system with some memory and services as skills and they will win the AI race

By Alex Zhavoronkov, PhD
Longevity Biotech Isn’t New—Build Sustainable Business First
SocialApr 4, 2026

Longevity Biotech Isn’t New—Build Sustainable Business First

Anyone who thinks that Longevity Biotechnology is new and in the next 10 years we will find a cure for aging with AI should read Paul Segall's "Living Longer, Growing Younger". 1989. Read "Merchants of Immortality" 2003 next. I think that the...

By Alex Zhavoronkov, PhD
GenAI Cryobiology Offers New Hope for Critical Patients
SocialApr 4, 2026

GenAI Cryobiology Offers New Hope for Critical Patients

Follow Wake Bio and its CEO, Mark Woodward, for cool news in high-throughput GenAI-driven cryobiology. P.S. I invested in this company personally and really like Mark and what he is doing. I hope that this technology will give patients we can...

By Alex Zhavoronkov, PhD
Incretin Modulators Boost Health, Happiness, and Longevity
SocialApr 4, 2026

Incretin Modulators Boost Health, Happiness, and Longevity

Life is a marshmallow test. Incretin modulators help you win while staying happy. I often ask big audiences - "how many of you are on GLP1?" and only a couple hands go up. Sometimes, none. That's when I understood that...

By Alex Zhavoronkov, PhD
Reasoning Data Enables Age Prediction Without Biological Samples
SocialApr 3, 2026

Reasoning Data Enables Age Prediction Without Biological Samples

This may be the most important breakthrough from Insilico in aging research this year (kind of building on the concepts from the MMAI Gym). Turns out, you do not need original biological data to train foundation models to predict...

By Alex Zhavoronkov, PhD
Grok 4.1 Surpasses Newer Models in Drug Discovery Benchmarks
SocialApr 2, 2026

Grok 4.1 Surpasses Newer Models in Drug Discovery Benchmarks

Whoa, @grok 4.1 beats many newer models in BVP. Btw. it is surprising that Grok does such a good job (not SOTA but better than frontier foundation models) in many drug discovery tasks https://t.co/UWaQZucawU

By Alex Zhavoronkov, PhD
First Extraterrestrial Contact: Aliens Seek Trade, Humans Have Chance
SocialApr 1, 2026

First Extraterrestrial Contact: Aliens Seek Trade, Humans Have Chance

Breakthrough News: Over the past 12 months we were working in secret on a clandestine project - the foundation model for search for and communication with Extracellular Life. Today, we managed to establish our first contact. The aliens want to engage...

By Alex Zhavoronkov, PhD
AI Cuts Drug Discovery From Years to Months
SocialMar 31, 2026

AI Cuts Drug Discovery From Years to Months

I joined Sam Fazeli for the latest episode of Bloomberg Intelligence's Vanguards of Healthcare podcast and talk about our partnership with Eli Lilly and why I believe algorithmic approaches are reshaping the earliest stages of pharmaceutical R&D. The biggest impact...

By Alex Zhavoronkov, PhD
Every Launch Counts; Follow Elon Musk's Playbook
SocialMar 30, 2026

Every Launch Counts; Follow Elon Musk's Playbook

Big deal today but also important stats - 28 PCCs, 12 clinical, 10+ deals. When you look at space companies - you look at launches to orbit. Every one counts. While you are launching on Falcon, you are building Starship....

By Alex Zhavoronkov, PhD
Future BCIs Could Let You Rent Out Your Brain
SocialMar 30, 2026

Future BCIs Could Let You Rent Out Your Brain

When we have a perfect BCI you may be able to rent out your brain for benefits #foreverai

By Alex Zhavoronkov, PhD
Global Debt Hits $111 Trillion; US, China Over Half
SocialMar 29, 2026

Global Debt Hits $111 Trillion; US, China Over Half

See how global government debt reached $111 trillion in 2025, with the U.S. and China together accounting for over half the total. https://t.co/rKkfcrsNdf via @visualcap

By Alex Zhavoronkov, PhD
First Earnings Call Unveils AI‑Driven Aging Therapies
SocialMar 28, 2026

First Earnings Call Unveils AI‑Driven Aging Therapies

Our first ever earnings call coming up tomorrow - we are reporting our 2025 annual results. I will start the call with the 5 minute introduction to AI drug discovery and how we measure AI drug discovery productivity. In my...

By Alex Zhavoronkov, PhD
Asia Emerges as Testbed for Healthcare Innovation
SocialMar 27, 2026

Asia Emerges as Testbed for Healthcare Innovation

It was a pleasure to participate in the Investment and Innovation Pathways to a Healthy Asia session at the Global Investors’ Symposium in Hong Kong. A timely discussion on where durable value is being created in healthcare across Asia, from prevention...

By Alex Zhavoronkov, PhD
AI Empowers Chemists, Accelerating Novel Drug Discovery
SocialMar 27, 2026

AI Empowers Chemists, Accelerating Novel Drug Discovery

The life of a chemist is about to change dramatically as we move away from tedious trial-and-error and deeper into the comfort of the prompt window. We don't need fewer medicinal chemists; we need more high-novelty drugs on the market...

By Alex Zhavoronkov, PhD
Pharma AI Shifts From Cloud to On‑Device
SocialMar 25, 2026

Pharma AI Shifts From Cloud to On‑Device

Most AI companies believe the future is cloud-first. Pharma is different. In this industry, data is the kingdom. Experimental data. Molecular designs. Clinical insights. Some of the most valuable intellectual property on Earth. And in many cases, it cannot leave the lab. This is where the typical...

By Alex Zhavoronkov, PhD
Hybrid PandaOmics‑Lobster Platform Accelerates Disease Target Discovery
SocialMar 25, 2026

Hybrid PandaOmics‑Lobster Platform Accelerates Disease Target Discovery

PandaOmics and Lobster hybrid for novel target discovery and disease hypothesis research. @steipete will have serious impact on human life

By Alex Zhavoronkov, PhD
AI-Driven Partnership Targets Unmet Gynecological Diseases
SocialMar 24, 2026

AI-Driven Partnership Targets Unmet Gynecological Diseases

We are very happy to join forces together with the wonderful ASKA to go after Novel Targets for Women's Health. Gynecological diseases have long posed challenges, including difficult diagnosis, limited treatment options, and a substantial disease burden, affecting millions of...

By Alex Zhavoronkov, PhD
AI Could Run Entire Companies and Revolutionize Drug Discovery
SocialMar 24, 2026

AI Could Run Entire Companies and Revolutionize Drug Discovery

Personally, I think that in two years (or less) the entire company can be run by AI including code generation and product deployment. Even humans can be controlled by AI (imagine yourself installed as a "skill" into the organizational AI)....

By Alex Zhavoronkov, PhD
Open‑source Super‑intelligent Model Accelerates Drug Discovery
SocialMar 23, 2026

Open‑source Super‑intelligent Model Accelerates Drug Discovery

Very important paper from our & @liquidai teams - deeply honored to have published with the geniuses @ramin_m_h & @xanamini . Take the super flexible model with high density of intelligence, post-train and fine-tune for basic...

By Alex Zhavoronkov, PhD
From Approval to Impact: Prioritize Results Over Perception
SocialMar 21, 2026

From Approval to Impact: Prioritize Results Over Perception

When I was 40, I really cared what people think about me and what I do. At almost 50, I only care about the results. I am cutting many activities to prioritize impact and maximize the value of time investment....

By Alex Zhavoronkov, PhD
WEF Report Highlights AI Driving Organizational Transformation
SocialMar 19, 2026

WEF Report Highlights AI Driving Organizational Transformation

Important report on the impact of AI in organizational transformation by the World Economic Forum. Happy to see Insilico presented as one of the case studies. https://t.co/rMr1W3aBDl https://t.co/dKcJAvvAHr

By Alex Zhavoronkov, PhD
China AI Boom Peaks; Baidu Leads Profitably
SocialMar 17, 2026

China AI Boom Peaks; Baidu Leads Profitably

The AI craze in China has peaked - Minimax briefly surpassed Baidu in market cap and is about the same now. Zhipu - very close. What is interesting is that Baidu is actually profitable and has $18B + in revenue....

By Alex Zhavoronkov, PhD
12-Year AI Drug Expert Unfamiliar
SocialMar 16, 2026

12-Year AI Drug Expert Unfamiliar

In my 12 years in AI drug discovery, I have not heard of this company, have you? Original Bloomberg post by @AmberTongPW https://t.co/9C4LY1c5Um and full text by China Dailly https://t.co/z3xG5Y5HBI https://t.co/fnddeGtdEW

By Alex Zhavoronkov, PhD
Approve Longevity Drugs for Disease First, Then Expand to Aging
SocialMar 15, 2026

Approve Longevity Drugs for Disease First, Then Expand to Aging

The only sustainable path to development of longevity therapeutics is to get the potential longevity drug approved for a disease, then go for indication expansion and study it in the context of aging at different doses and regimens. To be...

By Alex Zhavoronkov, PhD
Invasive BCI Advances Faster than Expected, Needs Major Backers
SocialMar 15, 2026

Invasive BCI Advances Faster than Expected, Needs Major Backers

Pretty big news in the BCI world today. Before Insilico, I was in BCI. I did not expect invasive interfaces to progress so quickly. The future will be amazing and I hope that Elon and Google put some serious muscle...

By Alex Zhavoronkov, PhD
Shanghai's
SocialMar 11, 2026

Shanghai's

I arrived in Shanghai and can not recognize it - there is an @openclaw craze. All high-end Mac products are sold out and there is a National push for OpenClaw adoption to boost productivity. @steipete is a local hero. I...

By Alex Zhavoronkov, PhD
Foundation Models Set to Transform Drug Discovery
SocialMar 9, 2026

Foundation Models Set to Transform Drug Discovery

Would you like to hear an opinion on how the future of drug discovery will look like as foundation models become more capable in drug discovery tasks? Check out our dialogue and the first pilot with the foundation model genius @ramin_m_h...

By Alex Zhavoronkov, PhD
TopTown SuperDNA Aims to End Aging by 2028
SocialMar 9, 2026

TopTown SuperDNA Aims to End Aging by 2028

We will solve aging or will die trying. Check out the TopTown SuperDNA project. It is no longer a concept - projected launch in Q3 2028. Fully-integrated residential-biotechnology-clinical infrastructure is key to longitudinal AI-powered drug discovery. https://t.co/LK5XaTci29

By Alex Zhavoronkov, PhD
Science Secures $230M Series C for Longevity Tech
SocialMar 6, 2026

Science Secures $230M Series C for Longevity Tech

Exciting news in the world of longevity via deep technology. Congratulations to @khoslaventures and @lightspeedvp on this historic investment. IMHO, Science may be bigger than OpenAI

By Alex Zhavoronkov, PhD